Ellis Investment Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $641K | Buy |
6,045
+707
| +13% | +$75K | 0.12% | 130 |
|
|
2025
Q1 | $663K | Buy |
5,338
+191
| +4% | +$23.7K | 0.14% | 122 |
|
|
2024
Q4 | $634K | Sell |
5,147
-666
| -11% | -$82K | 0.12% | 125 |
|
|
2024
Q3 | $648K | Sell |
5,813
-112
| -2% | -$12.5K | 0.13% | 130 |
|
|
2024
Q2 | $632K | Sell |
5,925
-3,280
| -36% | -$350K | 0.13% | 127 |
|
|
2024
Q1 | $1.11M | Buy |
9,205
+745
| +9% | +$89.7K | 0.24% | 80 |
|
|
2023
Q4 | $1.04M | Buy |
8,460
+3
| +0% | +$369 | 0.24% | 82 |
|
|
2023
Q3 | $1.09M | Sell |
8,457
-130
| -2% | -$16.8K | 0.28% | 76 |
|
|
2023
Q2 | $1.06M | Sell |
8,587
-221
| -3% | -$27.4K | 0.26% | 81 |
|
|
2023
Q1 | $1.29M | Hold |
8,808
| – | – | 0.33% | 72 |
|
|
2022
Q4 | $1.4M | Sell |
8,808
-835
| -9% | -$133K | 0.38% | 63 |
|
|
2022
Q3 | $1.29M | Hold |
9,643
| – | – | 0.36% | 64 |
|
|
2022
Q2 | $1.5M | Sell |
9,643
-50
| -0.5% | -$7.8K | 0.4% | 56 |
|
|
2022
Q1 | $1.51M | Buy |
9,693
+537
| +6% | +$83.5K | 0.36% | 59 |
|
|
2021
Q4 | $1.17M | Sell |
9,156
-2,518
| -22% | -$321K | 0.27% | 75 |
|
|
2021
Q3 | $1.52M | Buy |
11,674
+1,779
| +18% | +$232K | 0.38% | 57 |
|
|
2021
Q2 | $1.76M | Buy |
9,895
+3
| +0% | +$533 | 0.45% | 50 |
|
|
2021
Q1 | $1.63M | Sell |
9,892
-514
| -5% | -$84.5K | 0.45% | 49 |
|
|
2020
Q4 | $1.72M | Sell |
10,406
-2,291
| -18% | -$378K | 0.52% | 43 |
|
|
2020
Q3 | $1.81M | Buy |
12,697
+183
| +1% | +$26.1K | 0.64% | 37 |
|
|
2020
Q2 | $1.37M | Buy |
12,514
+850
| +7% | +$93.1K | 0.51% | 41 |
|
|
2020
Q1 | $1.12M | Buy |
11,664
+1,460
| +14% | +$140K | 0.53% | 42 |
|
|
2019
Q4 | $1.51M | Buy |
10,204
+1,015
| +11% | +$151K | 0.51% | 39 |
|
|
2019
Q3 | $1.16M | Buy |
9,189
+3,713
| +68% | +$470K | 0.42% | 46 |
|
|
2019
Q2 | $778K | Buy |
+5,476
| New | +$778K | 0.29% | 72 |
|